IP Library Granted Patent US 8,367,841
Granted Patent B2
US 8,367,841 · App. 12/617,757 · Granted Feb 5, 2013

Processes for the preparation of 1,2,4-oxadiazole benzoic acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,367,841
App. No.
12/617,757
Granted
Feb 5, 2013
Kind
B2
Abstract

Provided herein are processes for the preparation of compounds useful for the treatment, prevention or management of diseases associated with a nonsense mutation. More specifically, provided herein are processes for the synthesis of 1,2,4-oxadiazoles. In particular, provided herein are processes useful for the preparation of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid.

Claims (24)

1. A process for preparing a compound of the formula:

or a pharmaceutically acceptable salt thereof, comprising performing the following steps without isolation of an intermediate:

(1) reacting the cyanobenzoic acid methyl ester:

with hydroxylamine, to give:

followed by (2) acylation with 2-fluorobenzoyl chloride, to give:

followed by (3) condensation.

2. The process of claim 1 , wherein steps (1)-(3) are carried out in the same organic solvent.

3. The process of claim 2 , wherein the solvent is tert-butanol.

4. The process of claim 1 , further comprising:

(4) hydrolysis of the methyl ester of a compound of the formula:

to give:

or a pharmaceutically acceptable salt thereof.

5. A process for preparing a compound of the formula:

or a pharmaceutically acceptable salt thereof, comprising performing the following steps in the same organic solvent:

(1) reacting the cyanobenzoic acid methyl ester:

with hydroxylamine, to give:

followed by (2) acylation with 2-fluorobenzoyl chloride, to give:

followed by (3) condensation.

6. The process of claim 5 , wherein the solvent is tert-butanol.

7. The process of claim 5 , further comprising:

(4) hydrolysis of the methyl ester of a compound of the formula:

to give:

or a pharmaceutically acceptable salt thereof.

8. The process of claim 7 , wherein the hydrolysis is carried out in tert-butanol.

Assignments (6)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT @ REEL 061803 AND FRAME 0878 Recorded Oct 20, 2023
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: PTC THERAPEUTICS, INC.
Reel/Frame 065303/0163 →
SECURITY INTEREST Recorded Oct 28, 2022
From: PTC THERAPEUTICS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 061803/0878 →
RELEASE OF SECURITY INTEREST Recorded Jul 14, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: PTC THERAPEUTICS, INC.
Reel/Frame 053209/0872 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF 6420591,6583309,6503713, 5843995,7029846,7056656, 6468969,6486305,6630294, 6989256,6627398,8247167, 9017935 PREVIOUSLY RECORDED ON REEL 042418 FRAME 0774. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Aug 24, 2017
From: PTC THERAPEUTICS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 043672/0096 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2017
From: ALMSTEAD, NEIL G.; HWANG, PETER SEONGWOO; PINES, SEEMON; MOON, YOUNG-CHOON; TAKASUGI, JAMES J.
To: PTC THERAPEUTICS, INC.
Reel/Frame 043141/0489 →
SECURITY INTEREST Recorded May 8, 2017
From: PTC THERAPEUTICS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 042418/0774 →